Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Colebunders
R
R
Florence
E
E
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003906:Developing Countries; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014376:Tuberculosis / Q000517:prevention & control*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin